Analysis of Cimetidine Crystal Polymorphs by X-ray Absorption Near-Edge Spectroscopy
- 23 December 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 20 (2) , 1213-1221
Abstract
Sulfur K-edge X-ray absorption near-edge spectroscopy (XANES) measurements were performed to characterize the crystal polymorphs of the active pharmaceutical ingredients (APIs) containing sulfur atoms. Cimetidine (CIM) was used as a model API. Each crystal form of CIM has its own XANES spectrum, so we can discriminate the crystal form by its spectrum. The analysis of the crystal structure of CIM revealed that the difference in the shape of XANES spectra was ascribable to the difference in the C-S-C bond angle of CIM molecules and the intermolecular hydrogen bonds, such as C-H···S and N-H···S, and S-S interaction. It was found that the peak shape of the XANES spectrum is gentle when the C-S-C bond angle is large, while the peak shape can be steep when the C-S-C bond angle is small. Furthermore, it was found that the peak energy values varied depending on the hydrogen bonds and S-S interaction. By linear combination fitting using XANES spectra, it was possible to quantify the ratio of CIM form A crystal in mixed powders of form A and monohydrate crystals. These results indicate that XANES measurements can be a useful technique to evaluate the crystal polymorphism of APIs containing S atom in pharmaceutical formulation.Keywords
Funding Information
- Takeda Science Foundation
- Ministry of Education, Culture, Sports, Science and Technology (18K14641, 20K07001, 20K16058)
- Uehara Memorial Foundation
- Japan Prize Foundation
This publication has 28 references indexed in Scilit:
- ShelXle: a Qt graphical user interface forSHELXLJournal of Applied Crystallography, 2011
- Quantitative analysis of sulfathiazole polymorphs in ternary mixtures by attenuated total reflectance infrared, near-infrared and Raman spectroscopyJournal of Pharmaceutical and Biomedical Analysis, 2010
- Solid form screening – A reviewEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- Polymorph control: past, present and futureDrug Discovery Today, 2008
- Characterization and Selective Crystallization of Famotidine PolymorphsJournal of Pharmaceutical Sciences, 2007
- ATHENA,ARTEMIS,HEPHAESTUS: data analysis for X-ray absorption spectroscopy usingIFEFFITJournal of Synchrotron Radiation, 2005
- Pharmaceutical solid polymorphism in drug development and regulationAdvanced Drug Delivery Reviews, 2004
- Crystal structures of drugs: advances in determination, prediction and engineeringNature Reviews Drug Discovery, 2004
- Solid-state NMR and IR for the analysis of pharmaceutical solids: Polymorphs of fosinopril sodiumJournal of Pharmaceutical and Biomedical Analysis, 1993
- X-ray Structural Studies and Physicochemical Properties of Cimetidine PolymorphismJournal of Pharmaceutical Sciences, 1983